FDA amends policy on expedited review status for devices

03/10/2008 | FDAnews

The FDA has released a guidance under which devices can retain their expedited review status even if the agency has already cleared another device that has the same indication. The new policy, which terminates three conditions for premarket approval applications, aims to simplify the review process.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director Medical Affairs
Edwards Lifesciences
Irvine, CA
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Area Reimbursement Manager (CT, MA, MD, ME, NH, NJ, NY, PA, VT)
SI-BONE, INC
Multiple Locations, SL_Multiple Locations
Medical Director - Physician
Willamette Valley Community Health
Salem, OR
Medical Director - Physician
Willamette Valley Community Health
Salem, OR